Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S. (IST:ANGEN)

Market Cap	2.50B
Revenue (ttm)	529.83M
Net Income (ttm)	-218.88M
Shares Out	220.00M
EPS (ttm)	-0.99
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	6,782,308
Average Volume	5,250,956
Open	11.21
Previous Close	11.23
Day's Range	11.19 - 11.55
52-Week Range	10.31 - 21.12
Beta	-0.23
RSI	37.39
Earnings Date	Mar 10, 2025

About IST:ANGEN

Anatolia Tani ve Biyoteknoloji Ürünleri Ar-Ge Sanayi Ticaret A.S., a biotechnology company, engages in the design, development, and manufacture of real-time PCR kits, nucleic acid extraction kits, and automated nucleic acid extraction instruments in Turkey. It offers microbiology, genetic disorder, panel, sequencing, and food testing kits; and manual spin column and magnetic bead nucleic acid extraction kits, and automated NA extraction instrument kits. The company provides products for diseases, such as brucellosis, chlamydia trachomatis, cyto...

• Industry: Medical Devices
• Sector: Healthcare
• Employees: 223
• Stock Exchange: Istanbul Stock Exchange
• Ticker Symbol: ANGEN

Financial Performance

In 2024, IST:ANGEN's revenue was 529.83 million, an increase of 54.06% compared to the previous year's 343.92 million. Losses were -218.88 million, 10.9% more than in 2023.